Original articleOropharyngeal candidiasis with dry-powdered fluticasone propionate: 500 μg/day versus 200 μg/day
Section snippets
INTRODUCTION
Inhaled corticosteroids (ICS) have the properties of low systemic potency coupled with a high topical antiinflammatory activity. Among the local side effects, hoarseness and oropharyngeal candidiasis are the most common and clinically limiting factors. These side effects occur due to the deposition of the drug in the oropharynx. The incidence of oral candidiasis has varied from 1 % to 77 % with ICS treatment probably because of the method which is used to detect it1., 2.. It is well known that
METHODS
Two hundred thirty four asthmatic patients (58 male, 176 female) who were examined in our outpatient department were recruited to the study. 62 patients were taking 200 μg/d dry powdered FP and 122 patients were taking 500 μg/d dry powdered FP to control symptoms for at least three months. ICSs were delivered twice daily in all patients. 50 asthmatic patients who were seen as a first follow up and diagnosed as asthma were selected as asthmatic controls. They were not taking ICSs at least within
RESULTS
Demographic characteristics of the four study groups are shown in table I. Mean ages of subjects in each group were not statistically different (p > 0.05).
Table I also shows the frequencies and percentages of positive throat swabs for Candida in the four groups of subjects. Candida colonization was higher in those asthmatics who used 500 μg/d FP than controls (table I). Frequency of positive throat swabs for the patients with use of 200 μg/d FP was not different from asthmatics without ICS use (x2
DISCUSSION
The present study showed that ICSs increase oropharyngeal Candida colonization in higher doses of the drug. Although our 200 μg/d FP group had a higher frequency of Candida colonization than control groups, it did not reach statistical significance.
Local side effects are mainly seen in patients who use high doses of ICSs. Previous studies confirmed that the incidence of oral candidiasis is related to daily dose of inhaled steroid1,4. Our patients with 500 μg FP also showed higher frequency of
REFERENCES (8)
- et al.
Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered dose inhaler alone and with aerochamber
J Allergy Clin Immunol
(1988) - et al.
Candidiasis and dysphonia complicating beclomethasone treatment of asthma
J Allergy Clin Immunol
(1980) Local oropharyngeal side effects of inhaled corticosteroids in patients with asthma
Allergy
(2006)- et al.
The local side effects of inhaled corticosteroids: current understanding and review of the literature
Chest
(2004)